Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

被引：74
|
作者：
Cummings, J. [1 ]
Raynaud, F. [2 ]
Jones, L. [3 ]
Sugar, R. [4 ]
Dive, C. [1 ]
机构：
[1] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England
[2] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Haddow Labs, Sutton SM2 5NG, Surrey, England
[3] Canc Res UK, Translat Res Team, Clin & Translat Operat & Funding Directorate, London WC2A 3PX, England
[4] Canc Res UK, Drug Dev Off, Clin & Translat Operat & Funding Directorate, London WC2A 3PX, England
来源：
BRITISH JOURNAL OF CANCER | 2010年 / 103卷 / 09期
关键词：
biomarkers; validation; clinical trials; fit-for-purpose; BIOANALYTICAL METHOD VALIDATION; LIGAND-BINDING ASSAYS; CELL-DEATH; CANCER; MACROMOLECULES; STABILITY; QUALITY; SAMPLES;
D O I：
10.1038/sj.bjc.6605910
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Clinical development of new anticancer drugs can be compromised by a lack of qualified biomarkers. An indispensable component to successful biomarker qualification is assay validation, which is also a regulatory requirement. In order to foster flexible yet rigorous biomarker method validation, the fit-for-purpose approach has recently been developed. This minireview focuses on many of the basic issues surrounding validation of biomarker assays utilised in clinical trials. It also provides an overview on strategies to validate each of the five categories that define the majority of biomarker assays. British Journal of Cancer (2010) 103, 1313-1317. doi: 10.1038/sj.bjc.6605910 www.bjcancer.com Published online 5 October 2010 (C) 2010 Cancer Research UK
引用
收藏
页码：1313 / 1317
页数：5
相关论文
共 50 条
  • [31] Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)
    Goldsack, Jennifer C.
    Coravos, Andrea
    Bakker, Jessie P.
    Bent, Brinnae
    Dowling, Ariel V.
    Fitzer-Attas, Cheryl
    Godfrey, Alan
    Godino, Job G.
    Gujar, Ninad
    Izmailova, Elena
    Manta, Christine
    Peterson, Barry
    Vandendriessche, Benjamin
    Wood, William A.
    Wang, Ke Will
    Dunn, Jessilyn
    NPJ DIGITAL MEDICINE, 2020, 3 (01)
  • [32] Development and validation of a fit-for-purpose UHPLC-ESI-MS/MS method for the quantitation of cannabinoids in different matrices
    Zhao, Yang
    Sepehr, Estatira
    Vaught, Cory
    Yourick, Jeffrey
    Sprando, Robert L.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2023, 1218
  • [33] A framework for selecting a fit-for-purpose data collection method in land administration
    Rahrnatizadeh, Shima
    Rajabifard, Abbas
    Kalantari, Mohsen
    Ho, Serene
    LAND USE POLICY, 2018, 70 : 162 - 171
  • [34] Fit-for-purpose in veterinary drug residue analysis: Development and validation of an LC-MS/MS method for the screening of thirty illicit drugs in bovine urine
    Leporati, Marta
    Capra, Pierluigi
    Brizio, Paola
    Ciccotelli, Valentina
    Abete, Maria Cesarina
    Vincenti, Marco
    JOURNAL OF SEPARATION SCIENCE, 2012, 35 (03) : 400 - 409
  • [35] Biornarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs
    Wagner, J. A.
    Williams, S. A.
    Webster, C. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 104 - 107
  • [36] Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma
    Cleeland, Charles S.
    Keating, Karen N.
    Cuffel, Brian
    Elbi, Cem
    Siegel, Jonathan M.
    Gerlinger, Christoph
    Symonds, Tara
    Sloan, Jeff A.
    Dueck, Amylou C.
    Bottomley, Andrew
    Wang, Xin Shelley
    Williams, Loretta A.
    Mendoza, Tito R.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] Application of a structured process to identify fit-for-purpose data for pregnancy database study
    Meyers, Kristin J.
    Choong, Casey
    Irwin, Debra E.
    Kim, Sangmi
    Tang, Kathleen Y.
    Albright, Dawn G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 509 - 509
  • [38] Application of a Framework Qualifying Fit-for-Purpose Physiological Models to Drug Discovery and Development
    Azer, Karim
    Sachs, Jeffrey R.
    Cho, Carolyn R.
    Kerbusch, Thomas
    Cabal, Antonio
    Gibson, Christopher R.
    Allerheiligen, Sandra
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S26 - S27
  • [39] Recommendations for Development and Validation of a Fit-For-Purpose Biomarker Assays Using Western Blotting; An-AAPS Sponsored Initiative to Harmonize Industry Practices
    Kinhikar, Arvind
    Hassanein, Mohamed
    Harman, Jake
    Soderstrom, Catherine
    Honrine, Kimberly
    Lavelle, Amy
    Valentin, Marie-Anne
    Mathews, Joel
    AAPS JOURNAL, 2024, 26 (05):
  • [40] A conceptual method to evaluate the smart water system based on fit-for-purpose concept
    Zhang, Nan
    Khu, Soon-Thiam
    Wang, Jia
    ENVIRONMENTAL IMPACT ASSESSMENT REVIEW, 2024, 105
12345